Given its role in protecting cancer cells, targeting catalase could make cancer cells more susceptible to oxidative stress and enhance the efficacy of existing therapies. Research is ongoing to develop inhibitors of catalase that could be used in combination with other treatments to improve outcomes for cancer patients.
